HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Sook Jeong Selected Research

Catalytic RNA (Ribozymes)

1/2017Specific and Efficient Regression of Cancers Harboring KRAS Mutation by Targeted RNA Replacement.
7/2015Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation.
1/2015Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement.
1/2014Use of tumor-targeting trans-splicing ribozyme for cancer treatment.
8/2011Selective and efficient retardation of cancers expressing cytoskeleton-associated protein 2 by targeted RNA replacement.
1/2010In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.
1/2008Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
1/2008In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
12/2007Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
11/2007Molecular imaging of endogenous mRNA expression in a mouse tumor model by adenovirus harboring trans-splicing ribozyme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Sook Jeong Research Topics

Disease

22Neoplasms (Cancer)
01/2017 - 02/2004
7Neoplasm Metastasis (Metastasis)
04/2018 - 12/2007
5Hepatocellular Carcinoma (Hepatoma)
07/2015 - 08/2002
4Colorectal Neoplasms (Colorectal Cancer)
04/2018 - 02/2004
3Leukemia
09/2015 - 09/2009
3Colonic Neoplasms (Colon Cancer)
07/2012 - 01/2008
2Lymphatic Metastasis
04/2018 - 02/2004
2Infections
01/2017 - 12/2007
2Carcinogenesis
03/2015 - 02/2004
2Necrosis
12/2011 - 10/2004
2Liver Neoplasms (Liver Cancer)
05/2009 - 01/2008
2Peritoneal Neoplasms
01/2008 - 12/2007
2Stomach Neoplasms (Stomach Cancer)
12/2007 - 03/2004
1Breast Neoplasms (Breast Cancer)
04/2018
1Carcinoma (Carcinomatosis)
01/2015
1Glioma (Gliomas)
07/2012
1Inflammation (Inflammations)
12/2011
1Adenoma (Adenomas)
07/2010
1Adenocarcinoma
07/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2009
1Biliary Tract Neoplasms (Biliary Tract Cancer)
08/2009
1Ascites
12/2007
1Neoplasm Micrometastasis
03/2004

Drug/Important Bio-Agent (IBA)

10Catalytic RNA (Ribozymes)IBA
01/2017 - 11/2007
8RNA (Ribonucleic Acid)IBA
01/2017 - 12/2007
5Proteins (Proteins, Gene)FDA Link
01/2014 - 10/2004
4Telomerase (Telomerase Reverse Transcriptase)IBA
01/2015 - 12/2007
3Biological ProductsIBA
04/2018 - 02/2004
3Keratins (Keratin)IBA
09/2007 - 03/2004
2ProdrugsIBA
01/2017 - 01/2008
2Phosphotransferases (Kinase)IBA
09/2015 - 10/2004
2MicroRNAs (MicroRNA)IBA
07/2015 - 01/2015
2Thymidine KinaseIBA
01/2014 - 01/2010
2Coloring Agents (Dyes)IBA
12/2011 - 03/2007
2Fluorouracil (Carac)FDA LinkGeneric
08/2009 - 12/2007
2Messenger RNA (mRNA)IBA
01/2008 - 11/2007
2Complementary DNA (cDNA)IBA
02/2004 - 01/2003
1Biomarkers (Surrogate Marker)IBA
04/2018
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2018
1LipidsIBA
09/2015
1dihydroceramide desaturaseIBA
09/2015
1stichoposide DIBA
09/2015
1Small Interfering RNA (siRNA)IBA
09/2015
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2015
1Diazepam Binding InhibitorIBA
03/2015
1NucleotidesIBA
01/2014
1CeramidesIBA
11/2012
1stichoposideIBA
11/2012
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
07/2012
1Carcinoembryonic AntigenIBA
07/2012
1Nucleotide AptamersIBA
07/2012
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
07/2012
1Large Neutral Amino Acid-Transporter 1IBA
07/2012
1Indicators and Reagents (Reagents)IBA
07/2012
1Small Untranslated RNAIBA
07/2012
1Periodic AcidIBA
12/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2010
1ErbB Receptors (EGF Receptor)IBA
07/2010
1Interleukin-6 (Interleukin 6)IBA
07/2010
1Protein Kinases (Protein Kinase)IBA
09/2009
115-deoxyprostaglandin J2IBA
09/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2009
1NADPH Oxidases (NAD(P)H oxidase)IBA
09/2009
1Threonine (L-Threonine)FDA Link
09/2009
1Serine (L-Serine)FDA Link
09/2009
1GemcitabineFDA Link
08/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2009
1Mitomycin (Mitomycin-C)FDA LinkGeneric
08/2009
1Vitamin KFDA Link
05/2009
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2009
1acarboxyprothrombin (PIVKA)IBA
05/2009
1LuciferasesIBA
08/2008
1adenovirus receptorIBA
08/2008
1phosphorylethanolamine (phosphoethanolamine)IBA
08/2008
1Liposomes (Liposome)IBA
08/2008
1Ethylene Glycol (Monoethylene Glycol)IBA
08/2008
1Green Fluorescent ProteinsIBA
08/2008
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2008
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2007
1Leucovorin (Folinic Acid)FDA Link
12/2007
1apomucinIBA
09/2007
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
09/2007
1VimentinIBA
03/2007
1EmulsionsIBA
02/2005
1Antineoplastic Agents (Antineoplastics)IBA
02/2005
1GelatinIBA
02/2005
1Mitogen-Activated Protein KinasesIBA
10/2004
1MitogensIBA
10/2004
1Hydroxyurea (Hydrea)FDA LinkGeneric
10/2004
1beta-Galactosidase (Lactaid)IBA
10/2004
1Therapeutic UsesIBA
10/2004
1p38 Mitogen-Activated Protein KinasesIBA
10/2004
1TinIBA
03/2004
1Colloids (Colloid)IBA
03/2004
1Radioisotopes (Radionuclides)IBA
03/2004

Therapy/Procedure

4Therapeutics
03/2015 - 01/2008
3Drug Therapy (Chemotherapy)
08/2009 - 03/2007
1Salvage Therapy
08/2009
1Palliative Care (Palliative Therapy)
02/2005
1Lymph Node Excision (Lymph Node Dissection)
03/2004